Bayern Kapital

Munich, Germany
Firm Location:Munich, Germany • Germany
Bayern Kapital Team
INVESTORSINTRO STRENGTHSWEET SPOT (RANGE)INVESTMENT LOCATIONSTOP INVESTMENT CATEGORIES
n/a
$1.5M
($100K - $5.0M)
Investors in Germany
n/a
$1.5M
($100K - $5.0M)
Investors in Munich (Germany)
n/a
$1.5M
($100K - $5.0M)
Investors in Germany
n/a
$1.5M
($100K - $5.0M)
Investors in Munich (Germany)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B)
+5
Photo of Roman Huber, Managing Director at Bayern Kapital
Bayern Kapital
n/a
$1.5M
($100K - $5.0M)
Investors in Germany
Investors in SMB Software (Seed), Investors in BioTech (Seed), Investors in SMB Software (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed)
+3
n/a
$1.5M
($100K - $5.0M)
Investors in Munich (Germany)
n/a
$1.5M
($100K - $5.0M)
Investors in Germany
n/a
$1.5M
($100K - $5.0M)
Investors in Berlin (Germany)
n/a
$1.5M
($100K - $5.0M)
Investors in Munich (Germany)
n/a
$1.5M
($100K - $5.0M)
Investors in Germany
n/a
$1.5M
($100K - $5.0M)
Investors in Germany
n/a
$1.5M
($100K - $5.0M)
Investors in Munich (Germany)
Investors in SMB Software (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in SMB Software (Series B), Investors in SMB Software (Series A), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B)
+4
n/a
$1.5M
($100K - $5.0M)
Investors in Germany
n/a
$1.5M
($100K - $5.0M)
Investors in Germany
Photo of Georg Ried, Managing Director at Bayern Kapital
Bayern Kapital
n/a
$1.5M
($100K - $5.0M)
Investors in Germany
Investors in Medical Devices (Seed), Investors in SMB Software (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in SMB Software (Series B), Investors in SMB Software (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Digital Health (Series B), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed)
+10
n/a
$1.5M
($100K - $5.0M)
Investors in Germany
Photo of Bernd Schafberger, Managing Director at Bayern Kapital
n/a
$1.5M
($100K - $5.0M)
Investors in Germany
n/a
$1.5M
($100K - $5.0M)
Investors in Germany
n/a
$1.5M
($100K - $5.0M)
Investors in Germany
n/a
$1.5M
($100K - $5.0M)
Investors in Munich (Germany)
n/a
$1.5M
($100K - $5.0M)
Investors in Germany
n/a
($0 - $0)